Contributor Bio

Kevin Musni
Kevin Musni
Kevin has more than 8 years of professional experience focusing on general and real estate accounting, budget and cash flow analyses, and financial modeling. His expertise is on business process optimization, systems migration, and developing reasonable business policies. He is adept at utilizing multiple reporting software and other SaaS interfaces. He currently manages a mixture of Real Estate and Biotechnology groups in Scrubbed. Prior to Scrubbed, he worked at the Fraud, Claims, and Disputes Unit of JPMorgan Chase & Co.

Content

Capital Raising Opportunities and Challenges for Biotech and Life Sciences Companies

Biotech funding insights: navigate capital raising challenges and investor expectations.

Scaling Financial Operations in Life Sciences & Biotech with Fractional Teams

Biotech CFOs—see how fractional teams boost scalability and compliance in finance ops.

From R&D to ROI: How Outsourced Accounting Fuels Biotech Innovation

Unlock biotech innovation potential with outsourced accounting. Transform R&D investments into ROI drivers. Streamline financial processes efficiently.

Streamlining for Growth: Simplifying Account and Financial Processes in Biotech

Unlock biotech success with streamlined account and financial processes. Our solutions simplify complexities, fostering growth. Explore efficiency today.

5 Accounting FAQs on the Minds of Today’s Biotech Leaders

Navigating biotech's unique accounting challenges is crucial for success. Explore our Biotech Accounting FAQs for expert insights.

Why the Right Financial Plan is Critical for Biotech Startups

Biotech CFOs—see why structured financial planning drives investor confidence and growth.